Explore more Articles in

Stock Sectors

Markets Await Trade Deals as Trump Makes New Tariff Threats

Dollar edges higher, gold slips despite confusion and renewed trade tensions Trump delays tariff deadline to August 1, says trade deals are close Wall Street hits...

Gold Prices Under Pressure as Tariff Talks Offset Geopolitical Risks

Tariff Negotiations Weigh Down on Gold Gold () rose slightly on Friday as markets adjusted amid evolving trade headlines. However, it pulled back during the...

Oil Price Retreats but Bullish Technicals Suggest Upside Ahead

The NA session kicks off quietly, with subdued volumes as American traders take the day off, giving markets a breather after the upside surprise...

Stocks Week Ahead: Can Small-Business Optimism, Inflation Clues Keep Bulls Alive?

There’s not much on this week’s economic calendar. The only big event was supposed to occur on Wednesday, July 9. That would have been...
BioTech

AstraZeneca In $15 Billion Talks For Drug That Could Upend Lung Cancer Treatment – AstraZeneca (NASDAQ:AZN), Summit Therapeutics (NASDAQ:SMMT)

In a high-stakes maneuver that could reshape the oncology landscape, AstraZeneca Plc AZN is reportedly in talks with Summit Therapeutics Inc. SMMT about a...
BioTech

RFK Jr. Influence Evident As Vaccine Chief Overrules Scientists, Limits COVID-19 Vaccine Approval – Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA), Pfizer (NYSE:PFE)

Dr. Vinay Prasad, the U.S. Food and Drug Administration’s (FDA) top vaccine official, overruled agency scientists to limit approval of two COVID-19 vaccines, despite...
Energy Stocks

The Energy Report: Happy Oil Independence Day

We hold these truths to be self-evident, that all men are created equal, that they are endowed by their Creator with certain unalienable rights,...
BioTech

Why Is Novartis Stock Trading Lower – Novartis (NYSE:NVS)

Novartis AG NVS on Thursday released topline results from the Phase 3 GCAptAIN study evaluating Cosentyx (secukinumab) for newly diagnosed or relapsing giant cell...
BioTech

Regeneron’s Lynozyfic Gains Accelerated FDA Approval For Heavily Pre-Treated Multiple Myeloma – Regeneron Pharmaceuticals (NASDAQ:REGN)

The U.S. Food and Drug Administration (FDA) granted accelerated approval to Regeneron Pharmaceuticals, Inc.’s REGN Lynozyfic (linvoseltamab-gcpt) for adult patients with relapsed or refractory...
Energy Stocks

Gold Declines as Trade Optimism Reduces Safe-Haven Demand

On Thursday, the price of fell to 3,340 USD per troy ounce, partially correcting the previous day’s gains. The decline reflects growing optimism...
123...29Page 2 of 29

- A word from our sponsors -

Most Popular

Disclaimer: The content provided is for informational purposes only. We aim to keep the content current and accurate by updating it frequently. Sometimes the actual data can differ from what's stated on our website. Buttonwoodnews.com is an independent platform. While we are independent, we may be compensated for advertisements, sponsored products, or when you click on a link on our website. The contributors and authors are not registered or certified financial advisors. You should consult a financial professional before making any financial decisions.

Copyright © Button Wood News.